ARCHIVES

FDA Recruiting ODAC Consumer Rep Candidates

This article is from The Cancer Letter archive.

Vol. 21 No. 13 | March 31, 1995

Download PDF Visit The Full Archive

Related Articles

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Congress Approves FY 1980 HEW Funds

November 23, 1979

Patient Accrual Up More Than 20% This Year Despite Lack Of Significant New Money For Group

November 18, 1988

Final Issue Of the Year

December 14, 1990

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002